Pan genotypic response to combination treatment with Sofosbuvir and Daclatasvir in chronic Hepatitis C patients
Journal Title: International Journal of Biomedical Research - Year 2018, Vol 8, Issue 6
Abstract
Background and aims: Hepatitis C is a major cause of liver related morbidity and mortality. Prevalence of HCV infection in India has been variously estimated as 0.9 to 1.9%. With the advent of DAAs, the treatment has been revolutionized with more than 95% cure rate as observed in Caucasian population, while only scarce data on the same are available in the Indian population. Our study is aimed to assess the pan genotypic treatment response (SVR 12) to Sofosbuvir and Daclatasvir combination. Methods: Chronic hepatitis C patients who attended the department of gastroenterology in Calicut Medical College, Kerala, India were included in the study. All those patients with chronic hepatitis or compensated cirrhosis of liver received Sofosbuvir 400 mg and Daclatasvir 60 mg for 12 weeks and those with decompensated cirrhosis of liver received the both the drugs for 24 weeks. HCV RNA levels were measured at the beginning of the treatment, end of treatment and 12 weeks after completion of treatment. Results: 30 patients (22M: 8F) with a mean age of 478 years were included, of which 13 (43.3%) had cirrhosis of liver. Of the 13 Cirrhotic patients 9, 3, and 1 were in CTP A, B and C stage respectively. Among the total patients 23(76.7%), 5(16.7%), 2(6.7%) were genotype 3, 1 and 4 respectively .Three patients were treatment failure (previously treated with IFN and RBV combination), two were post renal transplant and one was a hemophilia patient. Median Viral load was: 499801 IU/ml (range: 2.4x10 3 -7.1x108), Median viral load in chronic hepatitis C patients and cirrhosis of liver patients were 2.8x106 and 1.3x106 IU/ml respectively. Overall ETR and SVR were 100% in patients across the genotype. No significant adverse reactions were observed. Conclusion: Combination treatment with Sofosbuvir and daclatasvir is very effective in chronic hepatitis patients with or without cirrhosis of liver, across the genotypes (Genotypes 1, 3 and 4)
Authors and Affiliations
Anup Sreedharan Nair, Thazhath Mavali Ramachandran, Prajob Prasad Geevarghese
Keywords
Related Articles
- EP ID EP452416
- DOI 10.7439/ijbr.v8i6.4220
- Views 132
- Downloads 0
Neutral Zone- A Clinical Report
Edentulism from a long term results in high resorption of lower edentulous ridge which often pose a problem in stability of mandibular complete dentures. It is a challenge for a prosthodontist to rehabilitate those patie...
Adolescent Pregnancy: An Assessment of a Rural Community in Plateau State, North Central Nigeria
Background: The incidence of adolescent pregnancy worldwide is on the increase and constitutes a major public health challenge.About 16 million women 15-19 years of age give birth each year and this account for 11% of al...
Increase in catheter associated urinary tract infections in intensive care units at a tertiary care centre: a cause of concern
Aim: Health-care associated infections (HAIs) affect 5-20% of patients admitted in the hospitals. Catheter-associated urinary tract infections (CAUTI) are the commonest HAIs accounting for about 35-45% of these nosocomia...
Is Apolipoprotein B and Small, Dense low density lipoprotein a better marker of cardiovascular risk?
The association between low density lipoprotein cholesterol and cardiovascular risk is well established. However, the measurement of the cholesterol content of this lipoprotein incompletely accounts for the risk of cardi...
Evaluation of the outcome of single session Extracorporeal Shock Wave Lithotripsy for the treatment of renal stones - Initial experience at a tertiary care hospital
Aim: To determine the efficacy of Extracorporeal Shock Wave Lithotripsy (ESWL) in patients with renal stones and to investigate the role of ESWL in improving treatment outcomes. Methods: A total of 93 patients who under...